CNBC World

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news

Silver-coated cicada wing amplifies molecular signals millions of timesWorldPing
Times of India

Silver-coated cicada wing amplifies molecular signals millions of times

Researchers developed a sensitive optical sensor using cicada wings and silver. This natural structure boosts weak molecular signals significantly, replacing expensive manufacturing. Silver coating on cicada wings creates tiny gaps that amplify light signals.

Brief by WorldPing · Original reporting by Times of India